TitleClinical Associate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
AddressOne Baylor Plaza
Houston, 77030
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    K23DK084513     (KOO, HOONMO LEE)Jul 1, 2009 - Jun 30, 2014
    Host Genetic Susceptibility and Immune Responses to Norovirus Infections
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Koo HS, Son HC, Lee HS, Goong HJ, Kim JS, Kim KB, Kwon YH, Kim JH, Shin HD, Shin JE, Jee SR. Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea. J Korean Med Sci. 2023 Apr 24; 38(16):e126. PMID: 37096309; PMCID: PMC10125791.
    2. Yu SJ, Lee HS, Gung HJ, Kim JS, Kim KB, Kwon YH, Kim JH, Koo HS, Shin HD, Jee SR, Lee HB, Kim J, Park HW, IBS Research Study Group of the Korean Society of Neurogastroenterology and Motility. Efficacy of a Restrictive Diet in Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis. Korean J Gastroenterol. 2022 07 25; 80(1):6-16. PMID: 35879058.
    3. Wang EW, Weekley A, McCarty J, Koo H, Lembcke B, Al Mohajer M. Impact of a division-wide bundle on hospital-acquired Clostridioides difficile cases, antibiotic days of therapy, testing appropriateness, and associated financial costs. Avicenna J Med. 2021 Jan-Mar; 11(1):27-32. PMID: 33520786; PMCID: PMC7839267.
    4. Song KH, Jung HK, Kim HJ, Koo HS, Kwon YH, Shin HD, Lim HC, Shin JE, Kim SE, Cho DH, Kim JH, Kim HJ, Clinical Practice Guidelines Group Under the Korean Society of Neurogastroenterology and Motility. Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition. J Neurogastroenterol Motil. 2018 Apr 30; 24(2):197-215. PMID: 29605976; PMCID: PMC5885719.
    5. Hwang SW, Kim JH, Im JP, Ye BD, Koo HS, Huh KC, Cheon JH, Kim YS, Kim YH, Han DS, Kim WH, Kim JS, Crohn's disease clinical network and cohort (CONNECT) study. Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study. J Gastroenterol Hepatol. 2017 Oct; 32(10):1716-1722. PMID: 28251684.
    6. Song KH, Hwang JA, Kim SM, Ko HS, Kang MK, Ryu KH, Koo HS, Lee TH, Huh KC, Choi YW, Kang YW. Acetic acid chromoendoscopy for determining the extent of?gastric intestinal metaplasia. Gastrointest Endosc. 2017 Feb; 85(2):349-356. PMID: 27515128.
    7. Jung Y, Hwangbo Y, Yoon SM, Koo HS, Shin HD, Shin JE, Moon HS, Kang SB, Lee JR, Huh KC. Predictive Factors for Differentiating Between Crohn's Disease and Intestinal Tuberculosis in Koreans. Am J Gastroenterol. 2016 08; 111(8):1156-64. PMID: 27296940.
    8. Lee YM, Huh KC, Yoon SM, Jang BI, Shin JE, Koo HS, Jung Y, Kim SH, Moon HS, Lee SW, Daejeon-Chungchung Intestinal Research Group. Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication. Gut Liver. 2016 Mar; 10(2):250-4. PMID: 26260753; PMCID: PMC4780455.
    9. Musher DM, Koo H. Non-toxigenic Clostridium difficile to prevent recurrent C. difficile infection. Evid Based Med. 2016 Apr; 21(2):67. PMID: 26763618.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    10. Garey KW, Aitken SL, Dima-Ala A, Beyda ND, Kuper K, Xie Y, Koo HL. Echinocandin use in hospitalized patients: a multi-institutional study. Am J Med Sci. 2015 Apr; 349(4):316-20. PMID: 25607510.
      Citations: 1     Fields:    Translation:Humans
    11. Lee JA, Lee TH, Kim JY, Seok MG, Kang MG, Jeong JH, Koo HS, Song KH, Kim YS, Kim SM, Huh KC, Choi YW, Kang YW. [Comparison of malnutrition risk between patients with liver cirrhosis and viral hepatitis carrier: a single center study]. Korean J Gastroenterol. 2014 Nov; 64(5):284-9. PMID: 25420738.
    12. Aitken SL, Hemmige VS, Koo HL, Vuong NN, Lasco TM, Garey KW. Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis. 2015 Jan; 81(1):4-8. PMID: 25445120.
      Citations: 11     Fields:    Translation:HumansCells
    13. Koo HL, Jiang ZD, Starke JR, DuPont HL, Crews JD. A hospital-based study of the clinical characteristics of Clostridium difficile infection in children. Pediatr Infect Dis J. 2014 Sep; 33(9):924-8. PMID: 25361022; PMCID: PMC4217137.
      Citations: 11     Fields:    Translation:HumansCells
    14. Koo HL, Van JN, Zhao M, Ye X, Revell PA, Jiang ZD, Grimes CZ, Koo DC, Lasco T, Kozinetz CA, Garey KW, DuPont HL. Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol. 2014 Jun; 35(6):667-73. PMID: 24799643.
      Citations: 40     Fields:    Translation:HumansCellsPHPublic Health
    15. Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, Garey KW. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother. 2014 Jun; 48(6):683-90. PMID: 24687545.
      Citations: 7     Fields:    Translation:HumansAnimals
    16. Darkoh C, Turnwald BP, Koo HL, Garey KW, Jiang ZD, Aitken SL, DuPont HL. Colonic immunopathogenesis of Clostridium difficile infections. Clin Vaccine Immunol. 2014 Apr; 21(4):509-17. PMID: 24477852; PMCID: PMC3993122.
      Citations: 10     Fields:    Translation:HumansCells
    17. Dinardo AR, Lewis DS, Koo HL, Goodman JC, Chiao E, Andrade R. Paradoxical immune reconstitution inflammatory syndrome due to toxoplasmic encephalitis: two cases and review of initiation of antiretroviral timing in toxoplasmic encephalitis IRIS. F1000Res. 2013; 2:133. PMID: 24358883; PMCID: PMC3814919.
      Citations: 5     Fields:    
    18. Koo HL, Neill FH, Estes MK, Munoz FM, Cameron A, DuPont HL, Atmar RL. Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination. J Pediatric Infect Dis Soc. 2013 Mar; 2(1):57-60. PMID: 23687584; PMCID: PMC3656546.
      Citations: 76     Fields:    
    19. Khalaf N, Crews JD, DuPont HL, Koo HL. Clostridium difficile: an emerging pathogen in children. Discov Med. 2012 Aug; 14(75):105-13. PMID: 22935207; PMCID: PMC4737473.
      Citations: 4     Fields:    Translation:HumansCells
    20. Koo HL, Sabounchi S, Huang DB, DuPont HL. Rifaximin therapy of irritable bowel syndrome. Clin Med Insights Gastroenterol. 2012; 5:31-41. PMID: 24833932; PMCID: PMC3987760.
      Citations: 3     
    21. Siddiq DM, Koo HL, Adachi JA, Viola GM. Norovirus gastroenteritis successfully treated with nitazoxanide. J Infect. 2011 Nov; 63(5):394-7. PMID: 21839773; PMCID: PMC3368802.
      Citations: 44     Fields:    Translation:HumansCells
    22. Koo HL, Ajami N, Atmar RL, DuPont HL. Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med. 2010 Jul; 10(50):61-70. PMID: 20670600; PMCID: PMC3150746.
      Citations: 74     Fields:    Translation:HumansCellsPHPublic Health
    23. Koo HL, Garey KW, Dupont HL. Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs. 2010 Jul; 19(7):825-36. PMID: 20521993; PMCID: PMC3159574.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    24. Shah D, Dang MD, Hasbun R, Koo HL, Jiang ZD, DuPont HL, Garey KW. Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther. 2010 May; 8(5):555-64. PMID: 20455684; PMCID: PMC3138198.
      Citations: 46     Fields:    Translation:HumansCells
    25. Koo HL, Ajami NJ, Jiang ZD, Neill FH, Atmar RL, Ericsson CD, Okhuysen PC, Taylor DN, Bourgeois AL, Steffen R, DuPont HL. Noroviruses as a cause of diarrhea in travelers to Guatemala, India, and Mexico. J Clin Microbiol. 2010 May; 48(5):1673-6. PMID: 20305012; PMCID: PMC2863947.
      Citations: 19     Fields:    Translation:HumansCells
    26. Koo HL, DuPont HL. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010 Jan; 26(1):17-25. PMID: 19881343; PMCID: PMC4737517.
      Citations: 45     Fields:    Translation:Humans
    27. Koo HL, Dupont HL, Huang DB. The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea. Ther Clin Risk Manag. 2009; 5:841-8. PMID: 19898648; PMCID: PMC2773752.
      Citations: 5     
    28. Koo HL, DuPont HL. Noroviruses as a potential cause of protracted and lethal disease in immunocompromised patients. Clin Infect Dis. 2009 Oct 01; 49(7):1069-71. PMID: 19705972.
      Citations: 12     Fields:    Translation:HumansCells
    29. Koo HL, Ajami NJ, Jiang ZD, Dupont HL, Atmar RL, Lewis D, Byers P, Abraham P, Quijano RA, Musher DM, Young EJ. A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection. Clin Infect Dis. 2009 Apr 01; 48(7):e75-7. PMID: 19245344; PMCID: PMC3761966.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    30. Vigil KJ, Jiang ZD, Chen JJ, Palumbo KL, Galbadage T, Brown EL, Yiang J, Koo H, DuPont MW, Ericsson C, Adachi JA, DuPont HL. Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, Texas. Am J Trop Med Hyg. 2009 Apr; 80(4):606-8. PMID: 19346385.
      Citations: 1     Fields:    Translation:CellsPHPublic Health
    31. Koo HL, Koo DC, Musher DM, DuPont HL. Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis. 2009 Mar 01; 48(5):598-605. PMID: 19191646.
      Citations: 26     Fields:    Translation:HumansCells
    32. Koo HL, Jiang ZD, Brown E, Garcia C, Qi H, Dupont HL. Coliform contamination of vegetables obtained from popular restaurants in Guadalajara, Mexico, and Houston, Texas. Clin Infect Dis. 2008 Jul 15; 47(2):218-21. PMID: 18540820.
      Citations: 4     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    33. Koo HL, Hamill RJ, Andrade RA. Drug-drug interaction between itraconazole and efavirenz in a patient with AIDS and disseminated histoplasmosis. Clin Infect Dis. 2007 Sep 15; 45(6):e77-9. PMID: 17712747.
      Citations: 8     Fields:    Translation:HumansAnimals
    34. Koo HL, DuPont HL. Current and future developments in travelers' diarrhea therapy. Expert Rev Anti Infect Ther. 2006 Jun; 4(3):417-27. PMID: 16771619.
      Citations: 6     Fields:    Translation:Humans
    35. Huang DB, Koo H, DuPont HL. Enteroaggregative Escherichia coli: An Emerging Pathogen. Curr Infect Dis Rep. 2004 Apr; 6(2):83-86. PMID: 15023269.
      Citations: 1     
    36. Huang DB, Koo H, Dougherty D, Hassan Y. Psychopathology among persons responding to participation as normal controls in behavioral research studies. Compr Psychiatry. 2003 Mar-Apr; 44(2):83-7. PMID: 12658616.
      Citations: 1     Fields:    Translation:Humans
    KOO's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (194)
    Co-Authors (17)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors